Výsledky vyhledávání - "P P M M, Geusens"

Akademický článek

Prevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht Study

Autor: Veerle van Hulten, Cindy Sarodnik, Johanna H. M. Driessen, Nicolaas C. Schaper, Piet P. M. M. Geusens, Carol A. B. Webers, Geert-Jan Dinant, Ramon P. G. Ottenheijm, Nicklas H. Rasmussen, Rikke Viggers, Coen D. A. Stehouwer, Carla J. H. van der Kallen, Miranda T. Schram, Sandrine P. G. Bours, Pieter C. Dagnelie, Joop P. van den Bergh

Publikováno v: Frontiers in Endocrinology, Vol 13 (2022)

BackgroundType 2 diabetes (T2D) is frequently reported to be associated with an increased fracture risk. Epidemiological data on prevalent morphometric vertebral fractures (VFs) in T2D are sparse and even less is known in the prediabetic state.Purpos

Externí odkaz: https://doaj.org/article/4c56f9dc04d1474bb9af9ea5836f5690

Zobrazit plný text záznamu

The fracture liaison service, a step forward not only in fracture reduction, but also in mortality reduction

Autor: W F, Lems, J P, van den Bergh, P P M M, Geusens

Publikováno v: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 33(8)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::58a939b879d17951c4259a2aae5ba710
https://pubmed.ncbi.nlm.nih.gov/35357521

Zobrazit plný text záznamu

[Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid]

Autor: P P M M, Geusens, W F, Lems

Publikováno v: Nederlands tijdschrift voor geneeskunde. 151(26)

A randomised, placebo-controlled study into the effects of the annual intravenous administration of zoledronic acid for the prevention of fractures in postmenopausal women with osteoporosis was recently published. Zoledronic acid, a bisphosphonate, i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1a84e1647cd8aa8c92d37295c73eb0e4
https://pubmed.ncbi.nlm.nih.gov/17633971

Zobrazit plný text záznamu

[Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy]

Autor: R N J, de Nijs, J W G, Jacobs, W F, Lems, R F J, Laan, A, Algra, A M, Huisman, E, Buskens, C E D, de Laet, J C M, Oostveen, P P M M, Geusens, G A W, Bruyn, B A C, Dijkmans, J W J, Bijlsmat

Publikováno v: Nederlands tijdschrift voor geneeskunde. 151(21)

To compare the effects of alendronate and alfacalcidol in the prevention ofglucocorticoid-related osteoporosis in patients with a rheumatic disease.Randomised, double-blind, double-placebo clinical trial (www. clinicaltrials.gov; number: NCT00138983)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2ec1c4b85c6c5a8798e733dc6294de83
https://pubmed.ncbi.nlm.nih.gov/17557758

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání